|
PTPRA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.742300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.360200E-01 |
| Normal-vs-Stage2 |
3.423900E-02 |
| Normal-vs-Stage3 |
3.37390000004767E-06 |
| Normal-vs-Stage4 |
6.41619999999232E-05 |
| Stage1-vs-Stage2 |
7.123800E-02 |
| Stage1-vs-Stage3 |
1.9919999999507E-06 |
| Stage1-vs-Stage4 |
6.31909999999625E-05 |
| Stage2-vs-Stage3 |
1.154350E-01 |
| Stage2-vs-Stage4 |
1.488600E-01 |
| Stage3-vs-Stage4 |
9.848800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.759100E-03 |
| Normal-vs-AfricanAmerican |
2.661400E-01 |
| Normal-vs-Asian |
8.629400E-01 |
| Caucasian-vs-AfricanAmerican |
4.326600E-01 |
| Caucasian-vs-Asian |
5.315400E-01 |
| AfricanAmerican-vs-Asian |
7.933600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.834000E-04 |
| Normal-vs-Female |
1.977360E-01 |
| Male-vs-Female |
1.666020E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.332400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.704200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.224700E-03 |
| Normal-vs-Age(81-100Yrs) |
3.087800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.316000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.138400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.324600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.843210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.432570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.690400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.656600E-03 |
| Normal-vs-Grade 2 |
6.594600E-01 |
| Normal-vs-Grade 3 |
1.97476000000085E-05 |
| Normal-vs-Grade 4 |
2.1881999999751E-06 |
| Grade 1-vs-Grade 2 |
1.525940E-02 |
| Grade 1-vs-Grade 3 |
3.58870000000122E-05 |
| Grade 1-vs-Grade 4 |
2.60409999996991E-06 |
| Grade 2-vs-Grade 3 |
2.31939999995046E-06 |
| Grade 2-vs-Grade 4 |
1.77580000004784E-06 |
| Grade 3-vs-Grade 4 |
1.552820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.276400E-01 |
| Normal-vs-ccB subtype |
3.560700E-04 |
| ccA subtype-vs-ccB subtype |
1.372400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.312070E-02 |
| Normal-vs-N1 |
3.224400E-03 |
| N0-vs-N1 |
1.525780E-01 |
|
|
